{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:15:53Z","timestamp":1783646153264,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T00:00:00Z","timestamp":1677024000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008001","name":"Universit\u00e4t zu K\u00f6ln","doi-asserted-by":"publisher","award":["4022-9548-0022-01"],"award-info":[{"award-number":["4022-9548-0022-01"]}],"id":[{"id":"10.13039\/501100008001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jgar.2023.02.010","type":"journal-article","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T19:48:50Z","timestamp":1677268130000},"page":"1-4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Activity of the old antimicrobial nitroxoline against Mycobacterium abscessus complex isolates"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3093-8417","authenticated-orcid":false,"given":"Ada Marie","family":"Hoffmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Wolke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Rybniker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Plum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7075-5378","authenticated-orcid":false,"given":"Frieder","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2023.02.010_bib0001","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.659997","article-title":"Mycobacterium abscessus complex: a review of recent developments in an emerging pathogen","volume":"11","author":"Victoria","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jgar.2023.02.010_bib0002","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.3201\/2109.141634","article-title":"Mycobacterium abscessus complex infections in humans","volume":"21","author":"Lee","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jgar.2023.02.010_bib0003","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1128\/IAI.01606-13","article-title":"Host response to nontuberculous mycobacterial infections of current clinical importance","volume":"82","author":"Orme","year":"2014","journal-title":"Infect Immun"},{"key":"10.1016\/j.jgar.2023.02.010_bib0004","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3201\/eid2406.172095","article-title":"Pulmonary infections with nontuberculous mycobacteria, Catalonia, Spain, 1994\u20132014","volume":"24","author":"Santin","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jgar.2023.02.010_bib0005","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3201\/eid2503.180572","article-title":"Epidemiology of extrapulmonary tuberculosis among inpatients, China, 2008\u20132017","volume":"25","author":"Pang","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jgar.2023.02.010_bib0006","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3201\/eid2203.151643","article-title":"Leveraging advances in tuberculosis diagnosis and treatment to address nontuberculous mycobacterial disease","volume":"22","author":"Raju","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jgar.2023.02.010_bib0007","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41579-020-0331-1","article-title":"Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus","volume":"18","author":"Johansen","year":"2020","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jgar.2023.02.010_bib0008","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1128\/JCM.01257-09","article-title":"Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in france","volume":"47","author":"Roux","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2023.02.010_bib0009","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jcf.2009.12.001","article-title":"Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis","volume":"9","author":"Esther","year":"2010","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jgar.2023.02.010_bib0010","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1055\/s-0035-1546751","article-title":"Nontuberculous mycobacteria in cystic fibrosis and non-cystic fibrosis bronchiectasis","volume":"36","author":"Park","year":"2015","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.jgar.2023.02.010_bib0011","doi-asserted-by":"crossref","DOI":"10.1039\/jr9540000570","article-title":"Some quinoline-5: 8-quinones","author":"Petrow","year":"1954","journal-title":"J of Chem. Soc. (Resumed)"},{"key":"10.1016\/j.jgar.2023.02.010_bib0012","doi-asserted-by":"crossref","first-page":"16349","DOI":"10.1021\/acs.jmedchem.1c01318","article-title":"Novel antimicrobial 8-hydroxyquinoline-based agents: current development, structure-activity relationships, and perspectives","volume":"64","author":"Joaquim","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.jgar.2023.02.010_bib0013","first-page":"226","article-title":"Activity in vitro of urine samples from patients treated by nitroxoline against mycoplasmas","volume":"4","author":"Amgar","year":"1989","journal-title":"J Chemother"},{"key":"10.1016\/j.jgar.2023.02.010_bib0014","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1093\/jac\/dkz275","article-title":"Susceptibility of carbapenemase-producing Enterobacterales (CPE) to nitroxoline","volume":"74","author":"Fuchs","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2023.02.010_bib0015","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1099\/jmm.0.001014","article-title":"In vitro activity of mecillinam and nitroxoline against Neisseria gonorrhoeae - re-purposing old antibiotics in the multi-drug resistance era","volume":"7","author":"Fuchs","year":"2019","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.jgar.2023.02.010_bib0016","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.cmi.2021.06.035","article-title":"Antifungal activity of nitroxoline against Candida auris isolates","volume":"27","author":"Fuchs","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2023.02.010_bib0017","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkac123","article-title":"In vitro activity of nitroxoline against carbapenem-resistant Acinetobacter baumannii isolated from the urinary tract","author":"Fuchs","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2023.02.010_bib0018","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkac123","article-title":"In vitro activity of nitroxoline in antifungal resistant Candida species isolated from the urinary tract","author":"Fuchs","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2023.02.010_bib0019","first-page":"406","article-title":"Roles of divalent cations and pH in mechanism of action of nitroxoline against Escherichia coli strains","volume":"42","author":"Pelletier","year":"1994","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.jgar.2023.02.010_bib0020","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1432-1033.1974.tb03597.x","article-title":"Rapid and selective inhibition of RNA synthesis in yeast by 8-hydroxyquinoline","volume":"46","author":"Fraser","year":"1974","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.jgar.2023.02.010_bib0021","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1093\/jac\/dky255","article-title":"Review of the pharmacokinetic properties of nitrofurantoin and nitroxoline","volume":"73","author":"Wijma","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2023.02.010_bib0022","first-page":"476","article-title":"Clinical pharmacokinetics of nitroxoline","volume":"17","author":"Mrhar","year":"1979","journal-title":"Int J Clin Pharmacol Biopharm"},{"key":"10.1016\/j.jgar.2023.02.010_bib0023","doi-asserted-by":"crossref","first-page":"5765","DOI":"10.1128\/AAC.00325-16","article-title":"8-Hydroxyquinolines are boosting agents of copper-related toxicity in Mycobacterium tuberculosis","volume":"60","author":"Shah","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2023.02.010_bib0024","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.906097","article-title":"In vitro activity of repurposed nitroxoline against clinically isolated mycobacteria including multidrug-resistant Mycobacterium tuberculosis","volume":"13","author":"Hoffmann","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jgar.2023.02.010_bib0025","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0924-8579(01)00437-X","article-title":"In vitro activity of the chelating agents nitroxoline and oxine against Mycobacterium bovis BCG","volume":"18","author":"Murugasu-Oei","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2023.02.010_bib0026","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/ddr.21531","article-title":"8-hydroxyquinolines are bactericidal against Mycobacterium tuberculosis","volume":"80","author":"Odingo","year":"2019","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.jgar.2023.02.010_bib0027","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1099\/ijsem.0.001376","article-title":"Emended description of Mycobacterium abscessus, Mycobacterium abscessus subsp. abscessus and Mycobacterium abscessus subsp. bolletii and designation of Mycobacterium abscessus subsp. massiliense comb. nov","volume":"66","author":"Tortoli","year":"2016","journal-title":"Int J Syst Evol Microbiol"},{"key":"10.1016\/j.jgar.2023.02.010_bib0028","series-title":"M24_3E: susceptibility testing of mycobacteria, Nocardia Spp., and other aerobic actinomycetes","year":"2018"},{"key":"10.1016\/j.jgar.2023.02.010_bib0029","unstructured":"EUCAST (2021). The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 11.0, 2021. http:\/\/www.eucast.org."},{"key":"10.1016\/j.jgar.2023.02.010_bib0030","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/jac\/dkz523","article-title":"Repurposing drugs for treatment of Mycobacterium abscessus: a view to a kill","volume":"75","author":"Gumbo","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2023.02.010_bib0031","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.1128\/AAC.00459-15","article-title":"Susceptibility of Mycobacterium abscessus to antimycobacterial drugs in preclinical models","volume":"59","author":"Obreg\u00f3n-Henao","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2023.02.010_bib0032","first-page":"207","article-title":"De le penetration de la nitroxoline dans le parenchyme prostatique\u00a0: essai therapeutique","volume":"3","author":"Dufour","year":"1979","journal-title":"J Urol Nephrol"},{"key":"10.1016\/j.jgar.2023.02.010_bib0033","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1590\/2175-8239-jbn-2018-0260","article-title":"Mycobacterium abscessus urinary tract infection: case report","volume":"42","author":"Laudelino","year":"2020","journal-title":"J Bras Nefrol"},{"key":"10.1016\/j.jgar.2023.02.010_bib0034","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3201\/eid2901.221531","article-title":"Successful treatment of Balamuthia mandrillaris granulomatous amebiceEncephalitis with nitroxoline","volume":"29","author":"Spottiswoode","year":"2023","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jgar.2023.02.010_bib0035","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/neuonc\/nou139","article-title":"Nitroxoline induces apoptosis and slows glioma growth in vivo","volume":"17","author":"Lazovic","year":"2015","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jgar.2023.02.010_bib0036","doi-asserted-by":"crossref","first-page":"19027","DOI":"10.18632\/oncotarget.3699","article-title":"Nitroxoline impairs tumor progression in vitro and in vivo by regulating cathepsin B activity","volume":"6","author":"Mirkovi\u0107","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jgar.2023.02.010_bib0037","doi-asserted-by":"crossref","first-page":"34974","DOI":"10.1021\/acsami.8b12812","article-title":"Albumin-stabilized metal-organic nanoparticles for effective delivery of metal complex anticancer drugs","volume":"10","author":"Hu","year":"2018","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.jgar.2023.02.010_bib0038","doi-asserted-by":"crossref","first-page":"346","DOI":"10.2174\/1871520619666190930124746","article-title":"Targeted nanoparticles for co-delivery of 5-FU and nitroxoline, a cathepsin B inhibitor, in HepG2 cells of hepatocellular carcinoma","volume":"20","author":"Varshosaz","year":"2020","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1016\/j.jgar.2023.02.010_bib0039","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1128\/AAC.49.10.4335-4338.2005","article-title":"Oral therapy using nanoparticle-encapsulated antituberculosis drugs in guinea pigs infected with Mycobacterium tuberculosis","volume":"49","author":"Johnson","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2023.02.010_bib0040","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s00120-017-0389-1","article-title":"Epidemiology, diagnostics, therapy, prevention and management of uncomplicated bacterial outpatient acquired urinary tract infections in adult patients: update 2017 of the interdisciplinary AWMF S3 guideline","volume":"56","author":"Kranz","year":"2017","journal-title":"Urologe A"},{"key":"10.1016\/j.jgar.2023.02.010_bib0041","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1186\/s12879-014-0628-7","article-title":"Review of the literature and individual patients' data meta-analysis on efficacy and tolerance of nitroxoline in the treatment of uncomplicated urinary tract infections","volume":"14","author":"Naber","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jgar.2023.02.010_bib0042","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1128\/AAC.02147-13","article-title":"Urinary concentrations and antibacterial activities of nitroxoline at 250 milligrams versus trimethoprim at 200 milligrams against uropathogens in healthy volunteers","volume":"58","author":"Wagenlehner","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2023.02.010_bib0043","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.cmi.2017.11.007","article-title":"Nitroxoline in geriatric patients with lower urinary tract infection fails to achieve microbiologic eradication: a noncomparative, prospective observational study","volume":"24","author":"Forstner","year":"2018","journal-title":"Clin Microbiol Infect"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716523000279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716523000279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:59:31Z","timestamp":1761991171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716523000279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":43,"alternative-id":["S2213716523000279"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2023.02.010","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activity of the old antimicrobial nitroxoline against Mycobacterium abscessus complex isolates","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2023.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}